Form 13-F position report

* DOLBY LABORATORIES INC

Reported by SCHRODER INVESTMENT MANAGEMENT GROUP

DLB CUSIP 25659T107 Manager CIK 0001086619

Reported 972,806 shares, down 57,646 (5.6%) from the prior quarter.

Reported value -12.6%; share count -5.6% vs. the prior quarter.

Reduced
% of reported 13F value 0.11% This manager · Q2 2022
Shares 972,806 Quarter-end amount reported
Reported value $70,713,000 Fair value at quarter end
Consecutive quarters held 20 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 53286000
2021-12-31 92538000
2022-03-31 80870000
2022-06-30 70713000
2022-09-30 60734000
2022-12-31 71002531
2023-03-31 84356778
2023-06-30 70996539
2023-09-30 56035630
2023-12-31 55989336
2024-03-31 56937297
2024-06-30 60460492
2024-09-30 89065103
2024-12-31 86154588
2025-03-31 83176161
2025-06-30 59917423
2025-09-30 20486536
2025-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

18 quarters
Quarterly reported position history for * DOLBY LABORATORIES INC held by SCHRODER INVESTMENT MANAGEMENT GROUP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2025 Reduced 0 -282,846 (-100.0%) 0 $0 2026-02-13
Q3 2025 Reduced 282,846 -524,014 (-64.9%) 0.02% $20,486,536 2025-11-13
Q2 2025 Reduced 806,860 -234,013 (-22.5%) 0.05% $59,917,423 2025-08-13
Q1 2025 Reduced 1,040,873 -62,824 (-5.7%) 0.08% $83,176,161 2025-05-13
Q4 2024 Reduced 1,103,697 -74,257 (-6.3%) 0.08% $86,154,588 2025-02-12
Q3 2024 Added 1,177,954 +414,853 (54.4%) 0.09% $89,065,103 2024-11-13
Q2 2024 Added 763,101 +83,415 (12.3%) 0.07% $60,460,492 2024-08-12
Q1 2024 Added 679,686 +30,007 (4.6%) 0.07% $56,937,297 2024-05-14
Q4 2023 Reduced 649,679 -57,306 (-8.1%) 0.07% $55,989,336 2024-02-14
Q3 2023 Reduced 706,985 -141,444 (-16.7%) 0.08% $56,035,630 2023-11-14
Q2 2023 Reduced 848,429 -139,124 (-14.1%) 0.1% $70,996,539 2023-08-11
Q1 2023 Reduced 987,553 -19,004 (-1.9%) 0.13% $84,356,778 2023-05-11
Q4 2022 Added 1,006,557 +74,332 (8.0%) 0.11% $71,002,531 2023-02-10
Q3 2022 Reduced 932,225 -40,581 (-4.2%) 0.1% $60,734,000 2022-11-14
Q2 2022 Reduced 972,806 -57,646 (-5.6%) 0.11% $70,713,000 2022-08-11
Q1 2022 Added 1,030,452 +58,621 (6.0%) 0.11% $80,870,000 2022-05-16
Q4 2021 Added 971,831 +366,304 (60.5%) 0.12% $92,538,000 2022-02-14
Q3 2021 Reduced 605,527 -65,804 (-9.8%) 0.08% $53,286,000 2021-11-12
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

385 managers reported * DOLBY LABORATORIES INC for Q2 2022.

Managers reporting * DOLBY LABORATORIES INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 6,191,117 -66,040 0.01% $443,037,000 37 qtrs
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC Added 4,052,837 +2,183,842 0.92% $290,021,000 9 qtrs
ATLANTA CAPITAL MANAGEMENT CO L L C Reduced 3,738,973 -9,000 1.15% $267,561,000 10 qtrs
Clearbridge Investments LLC Reduced 3,219,426 -99,188 0.21% $230,382,000 37 qtrs
BlackRock Inc Added 3,138,348 +14,502 < 0.01% $224,580,000 37 qtrs
Ninety One UK Ltd Reduced 2,662,638 -59,896 0.57% $190,538,000 4 qtrs
Jackson Square Partners LLC Reduced 2,629,576 -751,854 4.39% $188,172,000 7 qtrs
SOMA EQUITY PARTNERS LP Reduced 2,000,000 -300,000 7.57% $143,120,000 8 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Reduced 1,732,557 -45,782 0.03% $123,980,000 37 qtrs
DISCIPLINED GROWTH INVESTORS INC MN Added 1,620,572 +70,265 3.12% $115,968,000 37 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 11, 2022
Filing type
13F-HR
Position type
COM CL A

Voting authority reported

Sole
972,806
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.